Ritonavir-Induced Lipoatrophy and Dyslipidaemia Is Reversed by the Anti-Inflammatory Drug Leflunomide in a PPAR-γ-dependent Manner

Antiviral Therapy - United Kingdom
doi 10.3851/imp2039

Related search